EXAMINE Investigators

Author PubWeight™ 14.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Alogliptin after acute coronary syndrome in patients with type 2 diabetes.	N Engl J Med	2013	8.74
2	Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.	Lancet	2015	6.05
3	Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.	Hypertension	2016	0.81
4	Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndromes: the EXAMINE trial.	Diabetes Obes Metab	2017	0.77
5	Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.	Diabetes Care	2016	0.77
6	Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial.	Am Heart J	2016	0.75